Showing results (11-20 of 383) with videos related to
Sort By:
Pageof 39
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 12, 2026
Cost-savings from fracture prevention with zoledronate in randomised controlled trialsMark J Bolland, Andrew Grey, Ian R ReidClinical Endocrinology|February 27, 2010
Does calcium supplementation increase cardiovascular risk?Ian R Reid, Mark J Bolland, Andrew GreyTherapeutic Advances in Drug Safety|August 13, 2014
Calcium supplements and cardiovascular risk: 5 years onMark J Bolland, Andrew Grey, Ian R ReidClinical Medicine & Research|July 14, 2005
Lactoferrin--a novel bone growth factorDorit Naot, Andrew Grey, Ian R Reid, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 4, 2016
Durability of Response to Zoledronate Treatment and Competing Mortality in Paget's Disease of BoneTim Cundy, Katherine Maslowski, Andrew Grey, et al.Bone|May 10, 2011
The skeletal effects of the tyrosine kinase inhibitor nilotinibSusannah O'Sullivan, Jian-Ming Lin, Maureen Watson, et al.Maturitas|May 31, 2011
Calcium supplementation: balancing the cardiovascular risksIan R Reid, Mark J Bolland, Philip N Sambrook, et al.Calcified Tissue International|April 23, 2013
Testosterone levels following decreases in serum osteocalcinMark J Bolland, Andrew Grey, Anne M Horne, et al.The Lancet. Diabetes & Endocrinology|April 29, 2014
Vitamin D supplementation and falls: a trial sequential meta-analysisMark J Bolland, Andrew Grey, Greg D Gamble, et al.The American Journal of Clinical Nutrition|September 2, 2011
Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data setMark J Bolland, Andrew Grey, Greg D Gamble, et al.Pageof 39